Effect of dendritic cells (DC) vaccination on immunological parameters in patients with metastatic melanoma

被引:0
|
作者
Casamassima, Addolorata
Candeloro, Antonella
Scelsi, Michele
Morelli, Valentina
Lamacchia, Pasqua
Napoli, Luca
D'Agnelli, Maria Cosima
Quaranta, Michele
Guida, Michele
机构
[1] Inst Oncol, Expt Oncol Lab, Bari, Italy
[2] Osped San Paolo, Bari, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:645 / 645
页数:1
相关论文
共 50 条
  • [31] Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma:: a randomized phase III trial of the DC study group of the DeCOG
    Schadendorf, D
    Ugurel, S
    Schuler-Thurner, B
    Nestle, FO
    Enk, A
    Bröcker, EB
    Grabbe, S
    Rittgen, W
    Edler, L
    Sucker, A
    Zimpfer-Rechner, C
    Berger, T
    Kamarashev, J
    Burg, G
    Jonuleit, H
    Tüttenberg, A
    Becker, JC
    Keikavoussi, P
    Kämpgen, E
    Schuler, G
    ANNALS OF ONCOLOGY, 2006, 17 (04) : 563 - 570
  • [32] Sarcoidosis Under Dendritic Cell Vaccination Immunotherapy in Long-term Responding Patients with Metastatic Melanoma
    Uslu, Ugur
    Erdmann, Michael
    Schliep, Stefan
    Doerrie, Jan
    Schaft, Niels
    Schuler, Gerold
    Schuler-Thurner, Beatrice
    ANTICANCER RESEARCH, 2017, 37 (06) : 3243 - 3248
  • [33] Correlation between prior therapeutic dendritic cell vaccination and the outcome of patients with metastatic melanoma treated with ipilimumab
    Pierret, L.
    Wilgenhof, S.
    Corthals, J.
    Roelandt, T.
    Thielemans, K.
    Neyns, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
    Margarita Salcedo
    Nadège Bercovici
    Rachel Taylor
    Pierre Vereecken
    Séverine Massicard
    Dominique Duriau
    Frédérique Vernel-Pauillac
    Aurélie Boyer
    Véronique Baron-Bodo
    Eric Mallard
    Jacques Bartholeyns
    Béatrice Goxe
    Nathalie Latour
    Sophie Leroy
    Didier Prigent
    Philippe Martiat
    François Sales
    Marianne Laporte
    Catherine Bruyns
    Jean-Loup Romet-Lemonne
    Jean-Pierre Abastado
    Frédéric Lehmann
    Thierry Velu
    Cancer Immunology, Immunotherapy, 2006, 55 : 819 - 829
  • [35] Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
    Nestle, FO
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S25 - S25
  • [36] Durable clinical responses in patients with metastatic melanoma vaccinated with dendritic cells loaded with killed allogeneic melanoma cells.
    Fay, J. W.
    Ueno, H.
    Connolly, J.
    Banchereau, J.
    Palucka, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 119S - 119S
  • [37] Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results
    Trefzer, U
    Herberth, G
    Wohlan, K
    Milling, A
    Thiemann, M
    Sharav, T
    Sparbier, K
    Sterry, W
    Walden, P
    VACCINE, 2005, 23 (17-18) : 2367 - 2373
  • [38] Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
    Salcedo, M
    Bercovici, N
    Taylor, R
    Vereecken, P
    Massicard, S
    Duriau, D
    Vernel-Pauillac, F
    Boyer, A
    Baron-Bodo, V
    Mallard, E
    Bartholeyns, J
    Goxe, B
    Latour, N
    Leroy, S
    Prigent, D
    Martiat, P
    Sales, F
    Laporte, M
    Bruyns, C
    Romet-Lemonne, JL
    Abastado, JP
    Lehmann, F
    Velu, T
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (07) : 819 - 829
  • [39] Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
    Nestle, FO
    Alijagic, S
    Gilliet, M
    Sun, YS
    Grabbe, S
    Dummer, R
    Burg, G
    Schadendorf, D
    NATURE MEDICINE, 1998, 4 (03) : 328 - 332
  • [40] Dendritic cell vaccination of patients with metastatic colorectal cancer
    Burgdorf, Stefan K.
    DANISH MEDICAL BULLETIN, 2010, 57 (09)